Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Cubist Pharmaceuticals Inc    

CUBIST PHARMACEUTICALS INC
Mes dernières consult.
Most popular
  Report  
 SummaryNewsAnalysisCompany 
Company
Cubist Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the research, development and commercialization of pharmaceutical products.The company was founded in 1992 and is headquartered in Lexington, MA. 
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on CUBIST PHARMACEUTICALS INC
2015CUBIST PHARMACEUTICALS : Announces Withdrawal of Listing of CVRs (CBSTZ) from NA..
BU
2014CUBIST PHARMACEUTICALS : Announces FDA Approval of New Antibiotic ZERBAXA™..
BU
2014CUBIST PHARMACEUTICALS : SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Inves..
PR
2014CUBIST PHARMACEUTICALS : SHAREHOLDER ALERT: Brower Piven Launches An Investigati..
BU
2014CUBIST PHARMACEUTICALS : CBST SHAREHOLDER ALERT: The Law Offices of Vincent Wong..
BU
2014CUBIST PHARMACEUTICALS : SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Inv..
BU
2014CUBIST PHARMACEUTICALS : CBST SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces..
BU
2014CUBIST PHARMACEUTICALS : sales force seen as potential boon for Merck intestinal..
RE
2014Merck Reaffirms Commitment to Cubist Deal Despite Patent Ruling -- Update
DJ
2014CUBIST PHARMACEUTICALS : SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Inves..
PR
More news
Sector news : Biopharmaceuticals
05/25GRAIN HIGHLIGHTS : Top Stories of the Day
DJ
05/25LIVESTOCK HIGHLIGHTS : Top Stories of the Day
DJ
05/25ADRs End Lower; Major Oil Companies, Acorn International, and AstraZeneca Tra..
DJ
05/25Bayer cuts Monsanto synergy target by $300 million due to divestments
RE
05/25LONDON STOCK EXCHANGE : Oil weighs on FTSE, Kingfisher shines
RE
More sector news : Biopharmaceuticals
4-Traders Strategies on CUBIST PHARMACEUTICALS INC 
CUBIST PHARMACEUTICALS INC - 2013
Under a significant resistance
SELL
More Strategies
Managers
NameTitle
Martin Hermanus Soeters Director
Alison Francis Lawton Director
Kenneth J. Martin Director
Michael John Tomsicek Treasurer
Phyllis Rae Abbuhl Senior Sales Director-Western United States
Sector and Competitors
1st jan.Capitalization (M$)
CUBIST PHARMACEUTICALS INC0
CSL LIMITED0.00%62 614
BIOGEN-10.72%60 013
ALEXION PHARMACEUTICALS-1.22%26 064
GRIFOLS3.05%18 381
BIOMARIN PHARMACEUTICAL-0.80%15 600